|
COPG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.058810E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.079200E-01 |
| Normal-vs-Stage2 |
4.959200E-01 |
| Normal-vs-Stage3 |
2.731600E-01 |
| Normal-vs-Stage4 |
1.258120E-03 |
| Stage1-vs-Stage2 |
2.227000E-01 |
| Stage1-vs-Stage3 |
6.107800E-01 |
| Stage1-vs-Stage4 |
2.136900E-03 |
| Stage2-vs-Stage3 |
1.754840E-01 |
| Stage2-vs-Stage4 |
2.722400E-03 |
| Stage3-vs-Stage4 |
3.298400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.527800E-02 |
| Normal-vs-AfricanAmerican |
3.073200E-01 |
| Normal-vs-Asian |
8.346800E-01 |
| Caucasian-vs-AfricanAmerican |
1.868240E-02 |
| Caucasian-vs-Asian |
2.783200E-01 |
| AfricanAmerican-vs-Asian |
7.672000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.702400E-01 |
| Normal-vs-Female |
1.389430E-04 |
| Male-vs-Female |
5.55449999999347E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.904020E-01 |
| Normal-vs-Age(41-60Yrs) |
1.635630E-02 |
| Normal-vs-Age(61-80Yrs) |
4.233800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.860030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.466800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.988800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.337200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.036000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.700780E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.337880E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.939900E-02 |
| Normal-vs-Grade 2 |
9.572800E-01 |
| Normal-vs-Grade 3 |
1.527840E-01 |
| Normal-vs-Grade 4 |
3.421400E-03 |
| Grade 1-vs-Grade 2 |
5.556000E-02 |
| Grade 1-vs-Grade 3 |
1.935420E-01 |
| Grade 1-vs-Grade 4 |
8.664200E-01 |
| Grade 2-vs-Grade 3 |
1.573010E-01 |
| Grade 2-vs-Grade 4 |
3.502800E-03 |
| Grade 3-vs-Grade 4 |
3.131700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.095600E-01 |
| Normal-vs-ccB subtype |
2.147500E-02 |
| ccA subtype-vs-ccB subtype |
1.568230E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.366100E-02 |
| Normal-vs-N1 |
6.559000E-03 |
| N0-vs-N1 |
1.639900E-02 |
|
|
